Pathophysiology and clinical aspects of urinary lithiasis

Urologia Internationalis

Volumn 79, Issue SUPPL. 1, 2007, Pages 26-31

  Vella, M ^a   Karydi, M ^a   Coraci, G ^a   Oriti, R ^a   Melloni, D ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Pathophysiology, urinary lithiasis; Urolithiasis, clinical aspects

Indexed keywords

ALUMINUM; ANTICONVULSIVE AGENT; CALCIUM; CYSTINE; INDINAVIR; MAGNESIUM SILICATE; OXALIC ACID; PENICILLAMINE; PROTEINASE INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RITONAVIR; SAQUINAVIR; STRUVITE; TOPIRAMATE; TOSUFLOXACIN; URIC ACID; XANTHINE;

ARTICLE; CALCIUM METABOLISM; CLINICAL FEATURE; CLINICAL STUDY; CRYSTALLIZATION; DIET; DISEASE CLASSIFICATION; DISSOCIATION; DRUG ABSORPTION; GENETIC DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCALCIURIA; METABOLIC DISORDER; PRIORITY JOURNAL; URINARY TRACT INFECTION; URINARY TRACT MALFORMATION; UROLITHIASIS;

CALCIUM; CYSTINE; CYSTINURIA; DRUG THERAPY; HUMANS; HYPERCALCIURIA; HYPEROXALURIA; HYPERURICEMIA; KIDNEY; OXALIC ACID; URIC ACID; URINARY TRACT INFECTIONS; UROGENITAL ABNORMALITIES; UROLITHIASIS; XANTHINE;

EID: 34548250390     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104438     Document Type: Article

References (12)

1. Tiselius HG: Epidemiology and medical management of stone disease. BJU Int 2003;91:758-767.
2. Grases F, Sohnel O, Costa-Bauza A: Renal stone formation and development. Int Urol Nephrol 1999;31:591-600.
3. Weisinger JR: New insights into the pathogenesis of idiopathic hypercalciuria: the role of bone. Kidney Int 1996;49:1507-1518.
4. Burtis WJ, Gay L, Insogna KL, Eleison A, Broadus AE: Dietary hypercalciuria in patients with calcium oxalate kidney stones. Am J Clin Nutr 1994;60:424-429.
5. Hess B, Ackermann D, Essige M, Tackinen R, Jaeger PH: Renal mass and serum calcitriol in male idiopathic calcium renal stone formers: role of protein intake. J Clin Endocrinol Metab 1995;80:1916-1921.
6. Sidhu H, Allison MJ, Chow GM, Clark A, Peck AB: Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigens. J Urol 2001;166:1487-1491.
7. Asplin JR: Uric acid stones. Semin Nephrol 1996;16:412-424.
8. Langen H, von Kietzell D, Byrd D, Arslan-Kirchner M, Vester U, Stuhrmann M, Dork T, Saar K, Reis A, Schmidtke J, Brodehl J: Renal polyamine excretion tubular amino acid reabsorption and molecular genetics in cystinuria. Pediatr Nephrol 2000;14:376-384.
9. Matin SF, Streem S: Metabolic risk factors in patients with ureteropelvic junction obstruction and renal calculi. J Urol 2000;163:1676-1678.
10. Raj GV, Auge BK, Asimos D, Preminger GM: Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys. J Endourol 2004;18:157-161.
11. Daudon M, Estepa L, Viard G.P, Joly D, Jungers P: Urinary stones in HIV-1 positive patients treated with indinavir. Lancet 1997;349:1294-1295.
12. Ichiyanagi O, Nakada T, Ishigooka M, Hayami S, Sanjo Y, Kubota Y, Nakashima K, Sakai H, Kuwahara M: Pure silicate fragment in a recurrent stone former of calcium oxalate. Urol Int 1997;58:192-196.